Bayer

Asundexian first Factor XIa inhibitor approved in China for stroke risk reduction after priority review

26 Oct 2026

Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence

24 Oct 2026

Articles tagged with 'doccheck' | Bayer

22 Oct 2026

AskBio Announces 5 Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress

22 Oct 2026

EU and UK Risk Falling Further Behind Global Agricultural Competitors, Weakening Strategic Autonomy

15 Oct 2026

Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase II Combination Study in First-Line Patients with Advanced Colorectal Cancer

15 Oct 2026

Bayer Foundation honors five outstanding scientists with the Science Awards 2026

14 Oct 2026

U.S. FDA accepts Bayer’s supplemental New Drug Application for finerenone in chronic kidney disease without diabetes

08 Oct 2026

Bayer to invest 2.2 billion U.S. dollars in a new manufacturing site in the United States

03 Oct 2026

Bayer appoints Dr. Christoph Koenen, MD, as Chief Medical Officer

01 Oct 2026

View details about the software product Informachine News Trackers